Ann Rehabil Med.  2020 Oct;44(5):370-377. 10.5535/arm.19211.

Accuracy of Ultrasound-Guided and Non-guided Botulinum Toxin Injection Into Neck Muscles Involved in Cervical Dystonia: A Cadaveric Study

Affiliations
  • 1Department of Rehabilitation Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 2Department of Rehabilitation Medicine, St. Paul’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Abstract


Objective
To compare the accuracy of ultrasound-guided and non-guided botulinum toxin injections into the neck muscles involved in cervical dystonia.
Methods
Two physicians examined six muscles (sternocleidomastoid, upper trapezius, levator scapulae, splenius capitis, scalenus anterior, and scalenus medius) from six fresh cadavers. Each physician injected ultrasound-guided and non-guided injections to each side of the cadaver’s neck muscles, respectively. Each physician then dissected the other physician’s injected muscle to identify the injection results. For each injection technique, different colored dyes were used. Dissection was performed to identify the results of the injections. The muscles were divided into two groups based on the difficulty of access: sternocleidomastoid and upper trapezius muscles (group A) and the levator scapulae, splenius capitis, scalenus anterior, and scalenus medius muscles (group B).
Results
The ultrasound-guided and non-guided injection accuracies of the group B muscles were 95.8% and 54.2%, respectively (p<0.001), while the ultrasound-guided and non-guided injection accuracies of the group A muscles were 100% and 79.2%, respectively (p<0.05).
Conclusion
Ultrasound-guided botulinum toxin injections into inaccessible neck muscles provide a higher degree of accuracy than non-guided injections. It may also be desirable to consider performing ultrasound-guided injections into accessible neck muscles.

Keyword

Cervical dystonia; Ultrasonography; Botulinum toxins

Figure

  • Fig. 1. Ultrasound-guided injection into the scalenus anterior (SA) muscle. Intramuscular needle (arrow) is visible in this figure. SCM, sternocleidomastoid; BP, brachial plexus; SM, scalenus medius.

  • Fig. 2. Dissected cadaver with ultrasound-guided injection (blue and green dye, arrow) and non-guided injection (orange and purple dye, arrow head). The purple dye that targeted the scalenus medius muscle was misinjected into the scalenus posterior muscle. SA, scalene anterior; BP, brachial plexus; SM, scalene medius; SP, scalene posterior.


Reference

1. Velickovic M, Benabou R, Brin MF. Cervical dystonia pathophysiology and treatment options. Drugs. 2001; 61:1921–43.
2. Van den Dool J, Visser B, Koelman JH, Engelbert RH, Tijssen MA. Long-term specialized physical therapy in cervical dystonia: outcomes of a randomized controlled trial. Arch Phys Med Rehabil. 2019; 100:1417–25.
Article
3. Jinnah HA, Factor SA. Diagnosis and treatment of dystonia. Neurol Clin. 2015; 33:77–100.
Article
4. Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev. 2005; (1):CD003633.
Article
5. Hefter H, Benecke R, Erbguth F, Jost W, Reichel G, Wissel J. An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport). BMJ Open. 2013; 3:e001853.
6. Skogseid IM, Malt UF, Roislien J, Kerty E. Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia. Eur J Neurol. 2007; 14:1129–37.
Article
7. Comella C, Bhatia K. An international survey of patients with cervical dystonia. J Neurol. 2015; 262:837–48.
Article
8. Henzel MK, Munin MC, Niyonkuru C, Skidmore ER, Weber DJ, Zafonte RD. Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections. PM R. 2010; 2:642–6.
Article
9. Schnitzler A, Roche N, Denormandie P, Lautridou C, Parratte B, Genet F. Manual needle placement: accuracy of botulinum toxin A injections. Muscle Nerve. 2012; 46:531–4.
Article
10. Yang EJ, Rha DW, Yoo JK, Park ES. Accuracy of manual needle placement for gastrocnemius muscle in children with cerebral palsy checked against ultrasonography. Arch Phys Med Rehabil. 2009; 90:741–4.
Article
11. Kaymak B, Kara M, Gurcay E, Ozcakar L. Sonographic guide for botulinum toxin injections of the neck muscles in cervical dystonia. Phys Med Rehabil Clin N Am. 2018; 29:105–23.
Article
12. Schramm A, Baumer T, Fietzek U, Heitmann S, Walter U, Jost WH. Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement. J Neural Transm (Vienna). 2015; 122:1457–63.
Article
13. Brodsky MA, Swope DM, Grimes D. Diffusion of botulinum toxins. Tremor Other Hyperkinet Mov (N Y). 2012; 2:tre–02.
Article
14. Walter U, Dressler D. Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives. Expert Rev Neurother. 2014; 14:923–36.
Article
15. Fujimoto H, Mezaki T, Yokoe M, Mochizuki H. Sonographic guidance provides a low-risk approach to the longus colli muscle. Mov Disord. 2012; 27:928–9.
Article
16. Hong JS, Sathe GG, Niyonkuru C, Munin MC. Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia. Muscle Nerve. 2012; 46:535–9.
Article
17. Perotto AO. Anatomical guide for the electromyographer: the limbs and trunk. Springfield, IL: Charles C Thomas Publisher;2011.
18. Lee JH, Lee KY, Kim JY, Son WH, Jeong JH, Gil Jeong Y, et al. Botulinum toxin injection-site selection for a smooth shoulder line: an anatomical study. Biomed Res Int. 2017; 2017:3092720.
Article
19. Truong D, Dressler D, Hallett M. Manual of botulinum toxin therapy. Cambridge, UK: Cambridge University Press;2009.
20. Spinner DA, Kirschner JS, Herrera JE. Atlas of ultrasound guided musculoskeletal injections. New York, NY: Springer;2014.
21. Yi YG, Kim K, Yi Y, Choi YA, Leigh JH, Bang MS. Botulinum toxin type A injection for cervical dystonia in adults with dyskinetic cerebral palsy. Toxins (Basel). 2018; 10:203.
Article
22. Sutcliffe P, Lasrado S. Anatomy, head and neck, deep cervical neck fascia [Internet]. Treasure Island, FL: StatPearls Publishing;2020. [cited 2020 Aug 30]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK541091/.
23. Ziv YB, Kardosh R, Debi R, Backstein D, Safir O, Kosashvili Y. An inexpensive and accurate method for hip injections without the use of imaging. J Clin Rheumatol. 2009; 15:103–5.
Article
24. Sung DH, Choi JY, Kim DH, Kim ES, Son YI, Cho YS, et al. Localization of dystonic muscles with 18F-FDG PET/CT in idiopathic cervical dystonia. J Nucl Med. 2007; 48:1790–5.
Article
25. Lee IH, Yoon YC, Sung DH, Kwon JW, Jung JY. Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia. AJR Am J Roentgenol. 2009; 192:996–1001.
Article
26. Kaymak B, Kara M, Yagiz On A, Soylu AR, Ozcakar L. Innervation zone targeted botulinum toxin injections. Eur J Phys Rehabil Med. 2018; 54:100–9.
Article
Full Text Links
  • ARM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr